Stock listing

NASDAQ:LXEO Lexeo Therapeutics, Inc. Stock

Home listing (NASDAQ) of Lexeo Therapeutics, Inc.

Follow Lexeo Therapeutics, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:LXEO

$2.86 USD -0.38 (-11.6%)

Close on Nov 17, 2026

Past year -69.9% · daily closes, Nov 17, 2025 – Nov 17, 2026, adjusted for splits
Day range
$2.83 – $3.40 USDNov 17, 2026
Volume
3.95M sharesNov 17, 2026
Market cap
$234.4M USDAt the close on Nov 17, 2026 · price × 82.09M shares outstanding
52-week range
$2.55 – $10.99 USDLowest and highest trades, Nov 18, 2025 – Nov 17, 2026
Traded on an average day
$6.50M USDMedian day 1.11M shares · last 3 months, Aug 17, 2026 – Nov 17, 2026
Lexeo Therapeutics, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:LXEO · Home$2.855 USD-0.375 (-11.6%)3,949,214$3.31$3.40$2.83$3.23Close on Nov 17, 2026

Daily closes

Last 3 months, Aug 17, 2026 – Nov 17, 2026 · NASDAQ:LXEO · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$2.855-0.375-11.6%$3.31$3.40$2.833,949,214
$3.23+0.36+12.5%$3.55$4.30$3.0037,404,843
$2.87-0.04-1.4%$2.93$2.945$2.77446,440
$2.91-0.16-5.2%$3.02$3.05$2.821,717,454
$3.07+0.01+0.3%$3.09$3.21$3.035527,430
$3.06-0.08-2.5%$3.08$3.175$2.9351,008,290
$3.14+0.25+8.7%$2.99$3.22$2.791,336,057
$2.89-0.015-0.5%$2.815$2.959$2.701,007,027
$2.905-0.325-10.1%$3.23$3.37$2.7751,707,395
$3.23+0.12+3.9%$3.22$3.43$3.0351,191,155
$3.11+0.05+1.6%$3.10$3.30$3.011,309,251
$3.06-0.08-2.5%$3.16$3.18$2.991,218,590
$3.14+0.08+2.6%$3.10$3.295$2.901,001,519
$3.06-0.07-2.2%$3.16$3.375$3.051,046,020
$3.13+0.26+9.1%$2.85$3.14$2.781,198,286
$2.87+0.17+6.3%$2.71$2.935$2.652,684,072
$2.70-0.10-3.6%$2.80$2.825$2.6751,162,581
$2.80-0.09-3.1%$2.87$2.965$2.73619,400
$2.89-0.11-3.7%$2.98$3.12$2.89492,500
$3.00-0.02-0.7%$3.03$3.09$2.971,080,300
$3.02+0.26+9.4%$2.76$3.055$2.711,275,700
$2.76+0.12+4.5%$2.65$2.81$2.551,863,100
$2.64-0.12-4.3%$2.75$2.84$2.632,506,700
$2.76+0.13+4.9%$2.66$2.83$2.611,303,800
$2.63-0.11-4.0%$2.70$2.785$2.561,943,400
$2.74-0.30-9.9%$3.09$3.09$2.741,586,500
$3.04-0.19-5.9%$3.22$3.22$3.041,048,300
$3.23+0.02+0.6%$3.21$3.34$3.115961,400
$3.21-0.10-3.0%$3.27$3.28$3.1112,546,100
$3.31+0.01+0.3%$3.27$3.465$3.221,195,100
$3.30-0.11-3.2%$3.43$3.43$3.171,538,800
$3.41-0.12-3.4%$3.56$3.655$3.371,858,000
$3.53-0.09-2.5%$3.66$3.689$3.4952,592,100
$3.62+0.24+7.1%$3.38$3.68$3.2952,886,500
$3.38-0.04-1.2%$3.44$3.589$3.2753,053,800
$3.42+0.28+8.9%$3.14$3.59$2.986,560,000
$3.14-0.17-5.1%$3.27$3.29$3.141,256,700
$3.31-0.08-2.4%$3.40$3.455$3.271,007,100
$3.39-0.13-3.7%$3.50$3.50$3.331,484,600
$3.52-0.55-13.5%$4.07$4.09$3.4552,423,100
$4.07-0.01-0.2%$4.31$4.33$4.0353,092,300
$4.08-0.12-2.9%$4.24$4.335$4.04854,800
$4.20+0.02+0.5%$4.16$4.225$4.0592,287,800
$4.18+0.02+0.5%$4.27$4.38$4.141,099,100
$4.16+0.03+0.7%$4.16$4.22$4.09619,500
$4.13-0.08-1.9%$4.18$4.275$4.01888,400
$4.21-0.04-0.9%$4.31$4.36$4.181,263,700
$4.25-0.11-2.5%$4.43$4.475$4.2051,490,800
$4.36-0.12-2.7%$4.43$4.44$4.31420,900
$4.48-0.28-5.9%$4.72$4.805$4.48311,600
$4.76-0.13-2.7%$4.82$4.87$4.66357,800
$4.89+0.05+1.0%$4.76$4.99$4.76296,400
$4.84+0.06+1.3%$4.80$4.92$4.67313,300
$4.78+0.08+1.7%$4.76$4.96$4.65468,400
$4.70-0.06-1.3%$4.70$4.77$4.564420,500
$4.76-0.10-2.1%$4.82$4.82$4.62472,000
$4.86-0.13-2.6%$4.96$4.96$4.73663,600
$4.99-0.02-0.4%$4.97$5.09$4.8851,105,700
$5.01-0.12-2.3%$5.10$5.11$4.91690,000
$5.13+0.21+4.3%$4.97$5.13$4.94937,400
$4.92+0.04+0.8%$4.88$4.965$4.70518,500
$4.88-0.18-3.6%$5.12$5.204$4.84509,600
$5.06-0.31-5.8%$5.29$5.355$4.901,113,600
$5.37+0.44+8.9%$5.07$5.405$5.05941,900
$4.93-0.05-1.0%$4.94$5.05$4.825649,800
$4.98+0.14+2.9%$4.83$5.026$4.82913,800
Ticker
NASDAQ:LXEO
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Lexeo Therapeutics (NASDAQ:LXEO) Q3 2020 Earnings Call

    Mon, Nov 16, 2026 · 8:00 AM ET

    Watch Transcript

Latest news

All Lexeo Therapeutics, Inc. news

Financings

  • Public offering of common stock

    Oct 20, 2025

    Closed: US$143.8M raised · US$8 a share · Leerink Partners +4

    Dealers: Leerink Partners (co-lead), Cantor (co-lead), Stifel (co-lead), Oppenheimer & Co. (co-lead), Baird

    Announced Oct 16, 2025 · Update Oct 17, 2025 · Closed Oct 20, 2025

  • Private placement of pre-funded warrants

    Oct 20, 2025

    Closed: US$10M raised · US$7.9999 a share · Leerink Partners

    Dealers: Leerink Partners (lead)

    Buyers: Balyasny Asset Management (prefunded warrants to purchase 1,250,015 shares of common stock)

    Announced Oct 16, 2025 · Update Oct 17, 2025 · Closed Oct 20, 2025

  • Private placement of common stock or pre-funded warrants, with accompanying common warrants

    May 27, 2025

    Announced: about US$80M · US$2.8825 a share · ½ warrant at US$2.82 · J.P. Morgan +2

    Dealers: J.P. Morgan (co-lead), Oppenheimer & Co. (co-lead), Baird

    Buyers: Frazier Life Sciences (co-led the private placement); Janus Henderson Investors (co-led the private placement); Adar1 Capital Management; Affinity Healthcare Fund, LP; Ally Bridge Group; Coastlands Capital; Surveyor Capital (a Citadel company); Vestal Point Capital; Woodline Partners LP

    Use of proceeds: Advance ongoing clinical stage programs, working capital and general corporate purposes

    Announced May 27, 2025

Read by 6ix AI from the company's releases

Decks

Lexeo Therapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
24 in the last 12 months · 54 in all · newest Nov 15, 2026 · oldest 2023
Decks
23 decks · latest Nov 16, 2026

Where Lexeo Therapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:LXEO · Home listing · This pageNASDAQUnited StatesUSD
BOATS:LXEOBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Lexeo Therapeutics, Inc.